January lO, 1998 Dockets Management Branch (HFA-305) Food and Drug Administration[removed]Parklawn Drive, Room 1-23 Rockville, MD[removed]Re: Docket No. 97N-0217 Discussion Draft “Proposals to Increase the Availability

First Page		Document Content
Date: 1998-03-12 10:33:18 Health Pharmaceuticals policy Drug discovery Pharmaceutical industry Off-label use Minor Use Animal Drug Program Orphan drug Animal drugs Abbreviated New Drug Application Pharmaceutical sciences Food and Drug Administration Pharmacology		January lO, 1998 Dockets Management Branch (HFA-305) Food and Drug Administration[removed]Parklawn Drive, Room 1-23 Rockville, MD[removed]Re: Docket No. 97N-0217 Discussion Draft “Proposals to Increase the Availability Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 466,39 KB Share Document on Facebook

	Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID DocID: 1ptht - View Document
	PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296 DocID: 1pnIy - View Document
	Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry DocID: 1p93k - View Document
	Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DocID: 1m2hg - View Document
	Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc DocID: 1lmCl - View Document